Clinical Trial Update: Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessed the drug interaction between Miravirsen and Telaprevir in healthy subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Miravirsen (miravirsen)
• Telaprevir (telaprevir)

Snippet

Sponsor: Santaris Pharma A/S | Conditions: Hepatitis C, Chronic Hepatitis C | Phase 1 | Status: COMPLETED